It can inhibit E2F1 to regulate the cell cycle to affect the proliferation of hepatocellular carcinoma and regulate the proliferation of prostate cancer by suppressing ErbB2 (Wang et al., 2014b; Peng et al., 2021). Here, ERBB2 is linked to prostate carcinoma.